Key result
First-generation drug-eluting stents are associated with a stent thrombosis rate of 0.5% annually, a risk influenced by procedural factors, lesion morphology, and stent design.
Design
Review
Authors
Loading...
Highlights modifiable risks with first-generation stents; leaves open whether second-generation designs and DAPT optimization have lowered thrombosis rates.
Second-generation drug-eluting stents and optimal dual antiplatelet therapy are critical in mitigating the risk of stent thrombosis driven by procedural, patient, and lesion factors.
Sudhir et al. (2013) conducted a review in Coronary Drug-Eluting Stent Thrombosis. Drug-Eluting Stents was evaluated. First-generation drug-eluting stents are associated with a stent thrombosis rate of 0.5% annually, a risk influenced by procedural factors, lesion morphology, and stent design.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: